28941354|t|Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil.
28941354|a|Background Donepezil hydrochloride commonly used in the management of Alzheimer's disease (AD), exhibiting its inhibitory effects on acetylcholinesterase and butyrylcholinesterase activity thereby enhance cognitive function. Caffeic acid member of hydroxycinnamic acid is widely present in human diet. This study aims to investigate influence of caffeic acid on acetylcholinesterase and butyrylcholinesterase inhibitory properties of donepezil (in vitro). Methods 5 mg of donepezil was dissolved in 50 mL distilled water while 10 mg of caffeic acid was dissolved in 100 mL distilled water. Therefore, mixtures of samples were prepared as follows: A2=donepezil 0.075 mg/mL+caffeic acid 0.025 mg/mL; A3=donepezil 0.050 mg/mL+caffeic acid 0.050 mg/mL; A4=donepezil 0.025 mg/mL+caffeic acid 0.075 mg/mL. All samples were kept in the refrigerator at 4  C for subsequent analysis. Results The result showed that all the combinations show an inhibitory effect on acetylcholinesterase and butyrylcholinesterase activity in vitro, with the combination A4=donepezil 0.025 mg/mL+caffeic acid 0.075 mg/mL had significant (p<0.05) highest inhibitory effect on acetylcholinesterase and butyrylcholinesterase activity in vitro. More so, all the samples were able to prevent pro-oxidants (FeSO4 and sodium nitroprusside [SNP] ) induced lipid peroxidation in rat brain homogenate, with the combination A4=donepezil 0.025 mg/mL+caffeic acid 0.075 mg/mL and A3=donepezil 0.050 mg/mL+caffeic acid 0.050 mg/mL had highest inhibitory effect against FeSO4 and SNP induced lipid peroxidation in rat brain homogenate in vitro respectively. Moreover, all the samples exhibit antioxidant properties as typified by their ability to chelate iron (II) ion (Fe2+), hydroxyl radical (OH ) radical scavenging ability and ferric reducing property (FRAP). Conclusions Therefore, the combination of caffeic acid with donepezil enhances the antioxidant properties of donepezil. The combination of caffeic acid with donepezil could be a therapeutic aid in the management of AD, possibly with fewer side effects of donepezil. Nevertheless, the combination donepezil 0.025 mg/mL+caffeic acid 0.075 mg/mL acid look promising.
28941354	21	33	caffeic acid	Chemical	MESH:C040048
28941354	78	87	donepezil	Chemical	MESH:D000077265
28941354	100	123	Donepezil hydrochloride	Chemical	MESH:D000077265
28941354	159	178	Alzheimer's disease	Disease	MESH:D000544
28941354	180	182	AD	Disease	MESH:D000544
28941354	222	242	acetylcholinesterase	Gene	83817
28941354	247	268	butyrylcholinesterase	Gene	65036
28941354	314	326	Caffeic acid	Chemical	MESH:C040048
28941354	337	357	hydroxycinnamic acid	Chemical	MESH:D003373
28941354	379	384	human	Species	9606
28941354	435	447	caffeic acid	Chemical	MESH:C040048
28941354	451	471	acetylcholinesterase	Gene	43
28941354	476	497	butyrylcholinesterase	Gene	590
28941354	523	532	donepezil	Chemical	MESH:D000077265
28941354	561	570	donepezil	Chemical	MESH:D000077265
28941354	604	609	water	Chemical	MESH:D014867
28941354	625	637	caffeic acid	Chemical	MESH:C040048
28941354	672	677	water	Chemical	MESH:D014867
28941354	739	748	donepezil	Chemical	MESH:D000077265
28941354	761	773	caffeic acid	Chemical	MESH:C040048
28941354	790	799	donepezil	Chemical	MESH:D000077265
28941354	812	824	caffeic acid	Chemical	MESH:C040048
28941354	841	850	donepezil	Chemical	MESH:D000077265
28941354	863	875	caffeic acid	Chemical	MESH:C040048
28941354	1045	1065	acetylcholinesterase	Gene	83817
28941354	1070	1091	butyrylcholinesterase	Gene	65036
28941354	1135	1144	donepezil	Chemical	MESH:D000077265
28941354	1157	1169	caffeic acid	Chemical	MESH:C040048
28941354	1236	1256	acetylcholinesterase	Gene	83817
28941354	1261	1282	butyrylcholinesterase	Gene	65036
28941354	1362	1367	FeSO4	Chemical	-
28941354	1372	1392	sodium nitroprusside	Chemical	MESH:D009599
28941354	1409	1414	lipid	Chemical	MESH:D008055
28941354	1431	1434	rat	Species	10116
28941354	1477	1486	donepezil	Chemical	MESH:D000077265
28941354	1499	1511	caffeic acid	Chemical	MESH:C040048
28941354	1531	1540	donepezil	Chemical	MESH:D000077265
28941354	1553	1565	caffeic acid	Chemical	MESH:C040048
28941354	1616	1621	FeSO4	Chemical	-
28941354	1638	1643	lipid	Chemical	MESH:D008055
28941354	1660	1663	rat	Species	10116
28941354	1801	1814	iron (II) ion	Chemical	-
28941354	1816	1820	Fe2+	Chemical	-
28941354	1823	1845	hydroxyl radical (OH )	Chemical	-
28941354	1877	1883	ferric	Chemical	-
28941354	1952	1964	caffeic acid	Chemical	MESH:C040048
28941354	1970	1979	donepezil	Chemical	MESH:D000077265
28941354	2019	2028	donepezil	Chemical	MESH:D000077265
28941354	2049	2061	caffeic acid	Chemical	MESH:C040048
28941354	2067	2076	donepezil	Chemical	MESH:D000077265
28941354	2125	2127	AD	Disease	MESH:D000544
28941354	2165	2174	donepezil	Chemical	MESH:D000077265
28941354	2206	2215	donepezil	Chemical	MESH:D000077265
28941354	2228	2240	caffeic acid	Chemical	MESH:C040048
28941354	Negative_Correlation	MESH:C040048	65036
28941354	Negative_Correlation	MESH:C040048	83817
28941354	Negative_Correlation	MESH:C040048	MESH:D008055
28941354	Negative_Correlation	MESH:C040048	590
28941354	Negative_Correlation	MESH:D000077265	MESH:D000544
28941354	Negative_Correlation	MESH:C040048	MESH:D000077265
28941354	Negative_Correlation	MESH:D000077265	83817
28941354	Negative_Correlation	MESH:D000544	65036
28941354	Negative_Correlation	MESH:D000077265	MESH:D008055
28941354	Negative_Correlation	MESH:D000077265	43
28941354	Negative_Correlation	MESH:D000077265	590
28941354	Negative_Correlation	MESH:D000077265	65036

